Michael Alfieri insider trades
Open-market stock purchases and sales by Michael Alfieri, Principal Financial Officer at Aldeyra Therapeutics, Inc, from SEC Form 4 filings since Sep 13, 2018.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -27%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 18, 2026 | ALDX Aldeyra Therapeutics, Inc | Bought | $7.1K |